Synergistic PIM kinase and proteasome inhibition as a therapeutic strategy for MYC-overexpressing triple-negative breast cancer

Autor: Kunder, Ratika, Velyunskiy, Michelle, Dunne, Sara F., Cho, Byoung-Kyu, Kanojia, Deepak, Begg, Lauren, Orriols, Adrienne M., Fleming-Trujillo, Erica, Vadlamani, Pranathi, Vialichka, Alesia, Bolin, Rosemary, Perrino, Jessica N., Roth, Diane, Clutter, Matthew R., Zielinski-Mozny, Nicolette A., Goo, Young Ah, Cristofanilli, Massimo, Mendillo, Marc L., Vassilopoulos, Athanassios, Horiuchi, Dai

Publikováno v: In Cell Chemical Biology 17 March 2022 29(3):358-372

Improving thymus implantation for congenital athymia with interleukin‐7.

Autor: Min, Hyunjung, Valente, Laura A, Xu, Li, O'Neil, Shane M, Begg, Lauren R, Kurtzberg, Joanne, Filiano, Anthony J

Publikováno v: Clinical & Translational Immunology; 2023, Vol. 12 Issue 11, p1-13, 13p

S100A8/A9 predicts response to PIM kinase and PD-1/PD-L1 inhibition in triple-negative breast cancer mouse models.

Autor: Begg LR; Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Orriols AM; Northwestern University Feinberg School of Medicine, Chicago, IL, USA.; University of Florida College of Medicine, Gainesville, FL, USA., Zannikou M; Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Yeh C; Northwestern University Feinberg School of Medicine, Chicago, IL, USA.; Biostatistics Collaboration Center, Northwestern University, Chicago, IL, USA.; Rush University Medical Center, Chicago, IL, USA., Vadlamani P; Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Kanojia D; Northwestern University Feinberg School of Medicine, Chicago, IL, USA.; Mythic Therapeutics, Waltham, MA, USA., Bolin R; Center for Comparative Medicine, Northwestern University, Chicago, IL, USA.; Pennington Biomedical Research Center, Baton Rouge, LA, USA., Dunne SF; High Throughput Analysis Laboratory, Northwestern University, Evanston, IL, USA., Balakrishnan S; University of California, San Francisco, San Francisco, CA, USA.; Pulze.ai, San Francisco, CA, USA., Camarda R; University of California, San Francisco, San Francisco, CA, USA.; Novo Ventures US, Inc., San Francisco, CA, USA., Roth D; Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Zielinski-Mozny NA; Northwestern University Feinberg School of Medicine, Chicago, IL, USA.; Center for Comparative Medicine, Northwestern University, Chicago, IL, USA., Yau C; University of California, San Francisco, San Francisco, CA, USA., Vassilopoulos A; Northwestern University Feinberg School of Medicine, Chicago, IL, USA.; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.; AbbVie, Inc., North Chicago, IL, USA., Huang TH; Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Kim KA; Northwestern University Feinberg School of Medicine, Chicago, IL, USA.; Biostatistics Collaboration Center, Northwestern University, Chicago, IL, USA., Horiuchi D; Northwestern University Feinberg School of Medicine, Chicago, IL, USA. dai.horiuchi@northwestern.edu.; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA. dai.horiuchi@northwestern.edu.; Center for Human Immunobiology, Northwestern University, Chicago, IL, USA. dai.horiuchi@northwestern.edu.

Publikováno v: Communications medicine [Commun Med (Lond)] 2024 Feb 20; Vol. 4 (1), pp. 22. Date of Electronic Publication: 2024 Feb 20.